WO1996016633A1 - Bain de bouche a teneur reduite en alcool - Google Patents
Bain de bouche a teneur reduite en alcool Download PDFInfo
- Publication number
- WO1996016633A1 WO1996016633A1 PCT/US1995/012849 US9512849W WO9616633A1 WO 1996016633 A1 WO1996016633 A1 WO 1996016633A1 US 9512849 W US9512849 W US 9512849W WO 9616633 A1 WO9616633 A1 WO 9616633A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mouthwash composition
- alcohol
- reduced alcohol
- composition
- reduced
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 107
- 239000002324 mouth wash Substances 0.000 title claims abstract description 81
- 229940051866 mouthwash Drugs 0.000 title claims abstract description 72
- 230000002829 reductive effect Effects 0.000 title claims description 37
- 239000000203 mixture Substances 0.000 claims abstract description 109
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims abstract description 39
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 32
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 32
- 239000000600 sorbitol Substances 0.000 claims abstract description 32
- 239000000341 volatile oil Substances 0.000 claims abstract description 20
- 239000005844 Thymol Substances 0.000 claims abstract description 17
- 229960000790 thymol Drugs 0.000 claims abstract description 17
- 208000024693 gingival disease Diseases 0.000 claims abstract description 9
- 230000009467 reduction Effects 0.000 claims abstract description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 33
- 235000010356 sorbitol Nutrition 0.000 claims description 31
- 230000002421 anti-septic effect Effects 0.000 claims description 21
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 20
- 239000000796 flavoring agent Substances 0.000 claims description 18
- 235000019634 flavors Nutrition 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 14
- 150000005846 sugar alcohols Chemical class 0.000 claims description 13
- 239000004094 surface-active agent Substances 0.000 claims description 13
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 11
- 229960005233 cineole Drugs 0.000 claims description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 10
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 10
- 229920001983 poloxamer Polymers 0.000 claims description 10
- 229940041616 menthol Drugs 0.000 claims description 9
- 229960001047 methyl salicylate Drugs 0.000 claims description 9
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 8
- -1 entitol Chemical compound 0.000 claims description 8
- 239000002736 nonionic surfactant Substances 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 7
- 229920005862 polyol Polymers 0.000 claims description 7
- 150000003077 polyols Chemical class 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 229960000502 poloxamer Drugs 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 125000002091 cationic group Chemical group 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 4
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims description 4
- 230000002147 killing effect Effects 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001992 poloxamer 407 Polymers 0.000 claims description 3
- 229940044476 poloxamer 407 Drugs 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- FBPFZTCFMRRESA-FBXFSONDSA-N Allitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-FBXFSONDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 2
- 125000000129 anionic group Chemical group 0.000 claims 2
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 claims 1
- 206010006326 Breath odour Diseases 0.000 abstract description 10
- 210000000214 mouth Anatomy 0.000 abstract description 7
- 230000002265 prevention Effects 0.000 abstract description 6
- 235000019441 ethanol Nutrition 0.000 description 54
- 238000009472 formulation Methods 0.000 description 14
- 230000000844 anti-bacterial effect Effects 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000002158 endotoxin Substances 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003906 humectant Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- 229940076522 listerine Drugs 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229940011037 anethole Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 150000004673 fluoride salts Chemical class 0.000 description 2
- 239000000989 food dye Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000014666 liquid concentrate Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AZXBHGKSTNMAMK-UHFFFAOYSA-N 3-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=C(C)C=CC=C1O AZXBHGKSTNMAMK-UHFFFAOYSA-N 0.000 description 1
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Camphene hydrate Chemical compound C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013766 direct food additive Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011013 endotoxin removal Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019659 mouth feeling Nutrition 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Definitions
- the invention relates generally to mouthwashes for the prevention and elimination of bad breath as well as the reduction of oral microorganisms responsible for the development of dental plaque and tooth decay.
- Dental plaque can lead to the formation of calculus, gingivitis and other related gum diseases.
- the present invention relates to a reduced alcohol mouthwash that is effective in preventing those problems and is pleasant tasting as well.
- Oral rinse and mouthwash compositions have been used by people for many years for the prevention of bad breath and for the elimination of bacteria and other oral
- Alcohol is used both as a disinfectant and as a solvent in which the bactericidal active ingredients and additives such as astringents, fluorides, color additives, flavor oils, bactericidal actives and the like can be dissolved and then dispersed into solution.
- High levels of alcohol are generally used to provide an antiseptic function since lower concentrations are generally
- Alcohol also provides a preservative role for the mouthwash during storage and use as well as enhances the flavor oil organoleptic cues.
- Thymol for example, is a well known antiseptic compound also known as an essential oil which is utilized for its antimicrobial activity in a variety of mouthwash preparations.
- thymol can be utilized in oral hygiene compositions such as mouth rinses in
- Listerine ® is a well known
- antiseptic mouthwash that has been used by millions for over one hundred years and has been proven effective in killing bacteria in the oral cavity that are responsible for plaque, gingivitis and bad breath.
- Thymol together with other essential oils such as methyl salicylate, menthol and eucalyptol are active ingredients in
- antiseptic mouth rinses such as Listerine ® . These oils achieve their efficacy although present in minute amounts. Without being restricted to any specific theory, it is now believed that the efficacy and taste of antiseptic
- Dissolution is also important from an aesthetic point of view since a clear mouthwash solution is certainly preferred by
- polyoxypropylene block copolymer having about 50% to about 90% ethylene oxide, a humectant and a cationic
- composition allegedly exhibits a homogeneous, uniform appearance and high degree of bactericidal efficacy.
- emulsion-containing cleaning and coating compositions consisting of emulsion-containing cleaning and coating compositions that are non-irritating and low foaming for maximum plaque disruption and removal.
- the cleaning effect is achieved using an aqueous system containing a mouth conditioner comprising polydimethylsiloxane
- a surfactant such as a block copolymer of polyoxyethylene and polyoxybutylene.
- the composition consists of sodium
- an anionic surfactant such as sodium lauryl sulfate (0.05% w/v - 1.0% w/v) a non-ionic surfactant such as Tween (0.01% w/v - 3.0% w/v) and a humectant such as glycerol or sorbitol in amounts of from 30% w/v to 50% w/v.
- Alcohol may be added up to a level of 15% v/v with water comprising the remainder up to 100% w/v. It is postulated that the high levels of humectant cause the bacterial cell walls to swell causing separation of the cell wall and membrane. This enables the surfactants to enter the cell and deregulate autolysin enzymes which attack the cell wall causing holes and eventual cell lysis.
- United States Patent No. 5,236,699 to Libin teaches an antimicrobial mouthwash composition comprising two active agents, triclosan and cetylpyridium chloride.
- Ethanol comprises 15%-20% w/v of the water/alcohol carrier system and sorbitol is added in amounts of about 10%-15% by weight as a humectant.
- United States Patent No. 4,945,087 to Talwar et. al. discloses an oral antiseptic composition containing thymol, eucalyptol, menthol and methyl salicylate wherein the unpleasant, medicinal taste of thymol is masked using effective amounts of a mixture of a sugar alcohol such as sorbitol and anethole.
- the ethanol level claimed is 5-35% and levels of about 21.6% are disclosed.
- a reduced alcohol antibacterial mouthwash in which a substantially water insoluble non-cationic antibacterial/anti-plaque agent such as triclosan is dissolved in a solvent whose water/alcohol ratio is greater than 10:1.
- a substantially water insoluble non-cationic antibacterial/anti-plaque agent such as triclosan
- Sorbitol, glycerin and other sugar alcohols may be incorporated as humectants but nothing is attributed to their functioning as solubilizers or active enhancement compounds.
- U.S. Patent No. 5,100,650 to Carlin et. al. discloses an oral mouthwash with an antibacterial active such as chlorhexidine with non-ionic surfactants and high levels of sorbitol which it is asserted increase the antibacterial activity of the chlorhexidine compounds.
- Sorbitol solution (70%) is present in amounts of from about 40% w/v to about 60% w/v and the water/alcohol ratio ranges from about 3:1 to about 10:1 by weight.
- the present invention is a reduced alcohol
- antibacterial mouthwash composition with a high level of efficacy in the prevention of plaque, gum disease and bad breath.
- Sugar alcohols such as sorbitol surprisingly enhance the antimicrobial activity of the essential oil actives such as thymol even at these lower alcohol levels.
- the oral compositions are also pleasant tasting and present a clear, aesthetically appealing product.
- Figure 1 is a bar graph illustrating the effect of different sugar alcohol levels such as sorbitol on the biofilm critical kill times of essential oil-based mouthwash compositions comprised of about 21.6% v/v
- the reduced alcohol mouthwash compositions of the present invention provide an unexpected high degree of antiseptic efficacy towards oral microorganisms
- compositions of the present invention are pleasant tasting and their use leaves the mouth feeling clean and
- the enhanced antimicrobial efficacy of the reduced alcohol mouthwash compositions of the present invention is attributed to the presence of essential oils, (i.e., minor amounts of thymol, eucalyptol., menthol and methyl
- Methyl salicylate C 6 H 4 OHCOOCH 3
- wintergreen oil also known as wintergreen oil, additionally provides flavoring to the mouthwash together with its antimicrobial function.
- Eucalyptol C 10 H 18 O;
- cineol is a terpene ether and provides a cooling, spicy taste.
- Eucalyptol may be used in place of thymol in certain formulations in the same amount if desired.
- Menthol (CH 3 C 6 H 9 (C 3 H 7 )OH; hexahydrothymol) also is only slightly soluble in alcohol, is fairly volatile, and in addition to any antiseptic properties provides a cooling, tingling sensation.
- the total amount of essential oils present in a composition of this invention can be from 0.001% to about 0.35% by weight, based on the total weight of the composition, with about 0.16% to about 0.28% by weight of total volume of liquid oral preparation (% w/v) being preferred.
- the compositions of the present invention may contain thymol, and additionally eucalyptol, menthol, methyl salicylate, and mixtures thereof.
- the thymol is present in amounts of about 0.001% w/v to about 0.09% w/v by weight and most preferably form about to .04% w/v to about 0.07% w/v, said percent by weight being based on the total weight of the composition.
- Eucalyptol is present in amounts of about 0.001% w/v to about 0.11% w/v and preferably, from about 0.085% w/v to about 0.10% w/v.
- Menthol is preferably present in amounts of from about 0.001% to about 0.06% w/v and most preferably from about 0.035 to about 0.05% w.v.
- methyl salicylate is present in amounts of from about 0.001% to about 0.08% by weight and most preferably from about 0.04% to about 0.07%.
- the carrier for these essential oils is a water-alcohol
- Alcohol generally ethanol, serves as both a solvent for the actives, flavor oils, astringents,
- the alcohol solubilizes the antimicrobial actives and in so doing acts as an active enhancement mechanism.
- the actives are more readily dispersed throughout the solution and can attack pathogenic bacteria throughout the oral cavity. Reducing the alcohol levels adversely affects this enhancement mechanism.
- ethanol may be present in amounts of from about 12% v/v to about 22% v/v.
- the ratio of water to alcohol is in the range of from about 3:1 to about 25:1, preferably about 3.2:1 to about 10:1 by volume.
- the total amount of water-alcohol mixture in a mouthwash preparation is typically in the range from about 80% to about 99.9% by volume of the total composition.
- ethanol will be incorporated in amounts of from about 12% v/v to about 22% v/v.
- Polyols including the sugar alcohols, are selected from the group consisting of sorbitol, xylitol, mannitol, maltitol, inositol,
- hydrogenated starch hydroslyates, propylene glycol, polyethylene glycol, 1,3,-butanediol, allitol, altritol, dulcitol, galactitol, glucitol, hexitol, iditol, pentitol, ribitol, erythritol and mixtures thereof.
- Sorbitol is the preferred sugar alcohol in the practice of the present invention.
- the amount of sugar alcohol employed in the oral compositions of the present invention is directly
- surfactants are organic materials which aid in the complete dispersion of the ingredients throughout the solution as well as dispersing the preparation throughout the oral cavity.
- the surfactants incorporated in the compositions of the present invention are a blend of non-ionic and ionic surfactants which act together to solubilize the actives.
- the non-ionic surfactants are selected from the group known as poly(oxyethylene) poly(oxypropylene) block copolymers. Such copolymers are known commercially as poloxamers and are produced in a wide range of structures and molecular weights with varying contents of ethylene oxide.
- HLB Hydrophilic-Lipophilic Balance
- non-ionic surfactants useful in this invention include the following poloxamers:
- these polymers should constitute from about 0.01% w/v to about 8.0% w/v and preferably from about
- poloxamer is Poloxamer 407 which is incorporated in an amount of about 0.5% w/v.
- the poloxamer Due to the reduction of ethanol content the poloxamer is used to solubilize the essential oils and flavor oils otherwise not soluble in aqueous systems.
- the surfactant also acts to disperse the actives and flavors throughout the solution and enable the compositions to provide a clear, uniform appearance that is aesthetically more appealing.
- three types of peppermint oil, natural, Far West (Redistilled, terpeneless) and Rose Mitchum are combined to provide a triple blend.
- This unique blend of flavor oils not only provides a pleasant tasting mouthwash but also serves to taste mask the bitter tasting essential oil actives discussed above.
- Each peppermint oil is combined in substantially the same amount of from about 0.01% w/v to about 1.0% w/v and preferably, in an amount of from about 0.2% w/v to about 0.3% w/v.
- the triple blend is incorporated in the mouthwash composition in an amount of approximately 0.1% to about 2.0% and preferably in an amount of from about 0.5% to about 0.9%.
- the essential oil methyl salicylate not only provides antimicrobial action but, being a wintergreen flavor oil, also adds to the organoleptic flavor tones as well to complement this triple blend taste masking function of the other bitter tasting actives.
- Other flavor oils may also be added to further modify or magnify the cooling minty taste of the peppermint.
- Suitable flavors in particular include oil of anise (0.01% to about 0.2% w/v) and benzyl alcohol (0.001% w/v to about 0.1% w/v).
- the mouthwash is a clear, blue-green color and further includes spearmint oil (0.01% w/v to about 2.0% w/v) as an additional flavorant.
- Other flavors such as citrus oils, vanillin and the like may be incorporated to provide further taste variations.
- Additional components may be added as in conventional mouthwashes of the prior art. Whereas some alcohol containing mouthwashes have a pH of about 7.0, removal of the alcohol requires the addition of preservatives which drops the pH to unacceptable levels. Buffer systems are then necessary to control the pH of the composition at optimal levels. This is generally accomplished through the addition of a weak acid and its salt or a weak base and its salt. Useful systems have been found to be sodium benzoate and benzoic acid in amounts of from approximately 0.01% to about 2.0% w/v and sodium citrate and citric acid in amounts of from about 0.001% w/v to about 2.0% w/v and preferably from about 0.1% to about 0.2% w/v respectively. Preferably the buffers are incorporated in amounts that maintain the pH at levels of from approximately 3.5 to about 6.5 and more preferably, from about 4.0 to 5.0.
- Humectants such as polyethylene glycol may be added as an additional solubilizer for the flavor oils and these also provide texture to the composition. These are incorporated in amounts of approximately 0.3% w/v to about 0.6% w/v and preferably about 0.5% w/v. Softeners such as glycerin may be added to enhance the lubricous
- Glycerin is incorporated in amounts of approximately 1.0% w/v to about 10.0% w/v and preferably in an amount of about 7.5% w/v.
- Sweeteners such as aspartame or sodium saccharin may be added for better taste in amounts of from about 0.005% w.v to about 1.0% w.v and preferably in an amount of approximately 0.05% w/v.
- Zinc chloride may be added as an astringent for an "antiseptic cleaning" feeling in an amount of from about 0.0025% w/v to about 0.0075% w/v.
- the mouthwash formulations of the present invention may be formulated to be substantially clear and colorless, acceptably approved food dyes are preferably used to color. These may be selected from the long list of acceptable food dyes and in particular may be incorporated to provide the spearmint green formulation discussed infra.
- Suitable dyes for this purpose include FD & C yellow #5, yellow #10 and FD & C green #3 and these are added in amounts of from about .0003% w/v to about .0005% w/v or preferably from approximately 0.000035% w/v to about 0.00045% w/v.
- Water is added to q.s. and the formulation may then be bottled and packaged for shipping.
- the mouthwash composition of the present invention may also be formulated, if desired, as gels, foams, pastes, aerosols and tablets using standard formulations known in the art as appropriate.
- the mouthwash compositions of the present invention may be formulated in a dry powder or liquid concentrate form.
- the water is added to q.s. the volume to the necessary total is not added in order to prepare the liquid concentrate or what water is present is removed using standard evaporation procedures known in the art to prepare the dry powder form. Both may then have water added at a later date when ready for use.
- Such forms are advantageous for storage and shipping.
- An antibacterial oral composition of the present invention was prepared as follows.
- the active essential oils and flavor oils were first dissolved in ethanol in the following amounts.
- the flavor oil/essential oil active solution was combined and mixed with the remaining components as follows.
- the actives/flavors alcohol solution, benzoic acid and poloxamer 407 were first mixed and to this was added 300 ml. of deionized water and the sorbitol solution as continual mixing blended the ingredients.
- the sodium saccharin, sodium citrate and citric acid were also then added in order to realize or attain a composition pH of from about 3.9 to about 4.5, and preferably 4.2.
- the FD & C dyes were then added followed by sufficient deionized water to Q.S. the solution to 1.0 liter.
- the resulting oral composition was a clear blue-green color and possessed a pleasant, minty taste with little if any noticeable bitterness form the actives and the
- compositions of the present invention were measured on in-vitro bacterial cultures as a function of the amount of sorbitol incorporated therein. Reduced ethanol levels of about 21.6% w/v were used so that water comprised from about 75% w/v to about 80% w/v of the entire composition. As can be seen from the graph, there is a dramatic drop in the critical kill time of almost two minutes when sorbitol levels are increased from about 8% to about 25%. It has been found that the greater reduction in the critical kill times occurs when the sorbitol comprises from about 17% w/v to about 50% w/v.
- antibacterial mouthwash compositions were pleasant tasting when these higher sorbitol levels were employed.
- the antimicrobial mouthwash formulation as set forth in Example I was prepared with different levels of polyol. These were tested as to their efficacy as measured by the amount of endotoxin extracted from in vitro cultures of three Gram negative bacteria, Fusobacterium nucleatum,
- Actinobacillus actinomycetemcomitans (ATCC #33384) known plaque associated microorganisms. Endotoxin is a
- the cultures are treated with mouthwash compositions with no sorbitol versus those with 17.5% sorbitol as .the data reflect in Table 1.
- the cultures are washed with various mouthwash formulations and each mouthwash is then assayed for the amount of endotoxin contained therein which is indicative of each formulations efficacy as an antibacterial. Plus (+) signs indicate whether there has been any clotting of the assay which in turn indicates the presence of endotoxin while minus (-) signs indicate its absence.
- Table 2 reflects the comparative efficacy of several sorbitol levels in the mouthwash formulation of Example I, again with respect to the amount of endotoxin abstracted. The double signs indicate two assays were conducted for each formulation and dilution.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne un bain de bouche antimicrobien ayant un goût agréable, et qui est utile pour prévenir et combattre la mauvaise haleine, la formation de plaque et des maladies associées des gencives. Ces compositions contiennent une quantité efficace de thymol et d'autres huiles essentielles actives, ainsi que des niveaux accrus de sorbitol, qui améliore l'efficacité des matières actives dans la cavité buccale. Non seulement les matières actives permettent d'augmenter l'efficacité, mais elles sont complètement solubilisées dans des concentrations plus faibles d'alcool, de sorte qu'un produit d'un aspect visuel agréable soit obtenu.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU38902/95A AU3890295A (en) | 1994-12-02 | 1995-10-05 | Reduced alcohol mouthwash |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35337794A | 1994-12-02 | 1994-12-02 | |
US08/353,377 | 1994-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996016633A1 true WO1996016633A1 (fr) | 1996-06-06 |
Family
ID=23388844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/012849 WO1996016633A1 (fr) | 1994-12-02 | 1995-10-05 | Bain de bouche a teneur reduite en alcool |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3890295A (fr) |
WO (1) | WO1996016633A1 (fr) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0791362A2 (fr) | 1996-02-23 | 1997-08-27 | The Procter & Gamble Company | Compositions désinfectantes et procédé de désinfection de surfaces |
WO1997030685A1 (fr) * | 1996-02-23 | 1997-08-28 | Warner-Lambert Company | Bain de bouche a teneur alcoolique reduite |
US5830380A (en) * | 1997-07-18 | 1998-11-03 | Camco Manufacturing, Inc. | Methyl salicylate antifreeze solution method |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
US6103683A (en) * | 1996-01-12 | 2000-08-15 | The Procter & Gamble Co. | Disinfecting compositions and processes for disinfecting surfaces |
US6261540B1 (en) * | 1997-10-22 | 2001-07-17 | Warner-Lambert Company | Cyclodextrins and hydrogen peroxide in dental products |
US6348187B1 (en) * | 1996-01-24 | 2002-02-19 | Warner-Lambert Company | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems |
WO2002078663A1 (fr) * | 2001-03-29 | 2002-10-10 | Curozone Ireland Limited | Rinçage contenant un reducteur pour traitement a l'ozone de caries dentaires |
EP2433613A3 (fr) * | 2010-06-30 | 2013-05-22 | McNeil-PPC, Inc. | Solutions de rinçage de la bouche aux huiles essentielles bioactives sans alcool |
US8496915B2 (en) * | 2006-11-10 | 2013-07-30 | Matsutani Chemical Industry Co., Ltd. | Noncarious material and anticarious agent containing rare sugar |
RU2582222C2 (ru) * | 2010-06-30 | 2016-04-20 | МакНЕЙЛ-ППС, ИНК. | Способы получения неспиртовых ополаскивателей для полости рта с биологически активными эфирными маслами |
WO2018075384A1 (fr) * | 2016-10-20 | 2018-04-26 | Johnson & Johnson Consumer Inc. | Formulations de bain de bouche à teneur réduite en éthanol |
CN112336663A (zh) * | 2020-12-02 | 2021-02-09 | 陈倩倩 | 一种中药漱口水 |
US20220062196A1 (en) * | 2015-03-13 | 2022-03-03 | Nutrition 21, Llc | Arginine Silicate For Periodontal Disease |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2106394A1 (fr) * | 1970-09-09 | 1972-05-05 | Colgate Palmolive Co | |
EP0338978A2 (fr) * | 1988-03-31 | 1989-10-25 | Warner-Lambert Company | Masquage du goût du thymol |
EP0497476A2 (fr) * | 1991-01-30 | 1992-08-05 | Colgate-Palmolive Company | Compositions orales antiplaques |
WO1994007477A1 (fr) * | 1992-10-07 | 1994-04-14 | Warner-Lambert Company | Masquage du gout du thymol |
WO1994016674A1 (fr) * | 1993-01-27 | 1994-08-04 | Warner-Lambert Company | Antiseptique pour bains de bouche a teneur en alcool reduite et preparations |
WO1994018939A1 (fr) * | 1993-02-19 | 1994-09-01 | Warner-Lambert Company | Composition de rinçage utilisee avant le brossage |
DE4418796A1 (de) * | 1993-06-02 | 1994-12-15 | Colgate Palmolive Co | Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen |
-
1995
- 1995-10-05 AU AU38902/95A patent/AU3890295A/en not_active Withdrawn
- 1995-10-05 WO PCT/US1995/012849 patent/WO1996016633A1/fr active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2106394A1 (fr) * | 1970-09-09 | 1972-05-05 | Colgate Palmolive Co | |
EP0338978A2 (fr) * | 1988-03-31 | 1989-10-25 | Warner-Lambert Company | Masquage du goût du thymol |
US4945087A (en) * | 1988-03-31 | 1990-07-31 | Warner-Lambert Company | Taste masking of thymol |
EP0497476A2 (fr) * | 1991-01-30 | 1992-08-05 | Colgate-Palmolive Company | Compositions orales antiplaques |
WO1994007477A1 (fr) * | 1992-10-07 | 1994-04-14 | Warner-Lambert Company | Masquage du gout du thymol |
WO1994016674A1 (fr) * | 1993-01-27 | 1994-08-04 | Warner-Lambert Company | Antiseptique pour bains de bouche a teneur en alcool reduite et preparations |
WO1994018939A1 (fr) * | 1993-02-19 | 1994-09-01 | Warner-Lambert Company | Composition de rinçage utilisee avant le brossage |
DE4418796A1 (de) * | 1993-06-02 | 1994-12-15 | Colgate Palmolive Co | Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103683A (en) * | 1996-01-12 | 2000-08-15 | The Procter & Gamble Co. | Disinfecting compositions and processes for disinfecting surfaces |
US6348187B1 (en) * | 1996-01-24 | 2002-02-19 | Warner-Lambert Company | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems |
EP0791362A2 (fr) | 1996-02-23 | 1997-08-27 | The Procter & Gamble Company | Compositions désinfectantes et procédé de désinfection de surfaces |
WO1997030685A1 (fr) * | 1996-02-23 | 1997-08-28 | Warner-Lambert Company | Bain de bouche a teneur alcoolique reduite |
EP0791362A3 (fr) * | 1996-02-23 | 1998-03-04 | The Procter & Gamble Company | Compositions désinfectantes et procédé de désinfection de surfaces |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
US5830380A (en) * | 1997-07-18 | 1998-11-03 | Camco Manufacturing, Inc. | Methyl salicylate antifreeze solution method |
US6261540B1 (en) * | 1997-10-22 | 2001-07-17 | Warner-Lambert Company | Cyclodextrins and hydrogen peroxide in dental products |
WO2002078663A1 (fr) * | 2001-03-29 | 2002-10-10 | Curozone Ireland Limited | Rinçage contenant un reducteur pour traitement a l'ozone de caries dentaires |
US6649148B2 (en) | 2001-03-29 | 2003-11-18 | Curozone Ireland Limited | Reductant rinse for use with ozone treatment of dental caries |
US20130344008A1 (en) * | 2006-11-10 | 2013-12-26 | National University Corporation Kagawa University | Noncarious material and anticarious agent containing rare sugar |
US9668958B2 (en) | 2006-11-10 | 2017-06-06 | Matsutani Chemical Industry Co., Ltd. | Noncarious material and anticarious agent containing rare sugar |
US8496915B2 (en) * | 2006-11-10 | 2013-07-30 | Matsutani Chemical Industry Co., Ltd. | Noncarious material and anticarious agent containing rare sugar |
US9763863B2 (en) | 2010-06-30 | 2017-09-19 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
RU2582222C2 (ru) * | 2010-06-30 | 2016-04-20 | МакНЕЙЛ-ППС, ИНК. | Способы получения неспиртовых ополаскивателей для полости рта с биологически активными эфирными маслами |
US9084902B2 (en) | 2010-06-30 | 2015-07-21 | Mcneil-Ppc, Inc. | Non-alchohol bioactive essential oil mouth rinses |
US9693944B2 (en) | 2010-06-30 | 2017-07-04 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
EP2433613A3 (fr) * | 2010-06-30 | 2013-05-22 | McNeil-PPC, Inc. | Solutions de rinçage de la bouche aux huiles essentielles bioactives sans alcool |
EP3427718A1 (fr) * | 2010-06-30 | 2019-01-16 | Johnson & Johnson Consumer Inc. | Solutions de rinçage de la bouche aux huiles essentielles bioactives sans alcool |
US10434050B2 (en) | 2010-06-30 | 2019-10-08 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
US10993894B2 (en) | 2010-06-30 | 2021-05-04 | Johnson & Johnson Consumer Inc. | Methods of preparing non-alcohol bioactive essential oil mouth rinses |
US20220062196A1 (en) * | 2015-03-13 | 2022-03-03 | Nutrition 21, Llc | Arginine Silicate For Periodontal Disease |
WO2018075384A1 (fr) * | 2016-10-20 | 2018-04-26 | Johnson & Johnson Consumer Inc. | Formulations de bain de bouche à teneur réduite en éthanol |
US9974722B2 (en) | 2016-10-20 | 2018-05-22 | Johnson & Johnson Consumer Inc. | Reduced-ethanol mouth rinse formulations |
CN112336663A (zh) * | 2020-12-02 | 2021-02-09 | 陈倩倩 | 一种中药漱口水 |
Also Published As
Publication number | Publication date |
---|---|
AU3890295A (en) | 1996-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5817295A (en) | Alcohol free mouthwash | |
US5723106A (en) | Reduced alcohol mouthwash antiseptic and antiseptic preparation | |
US6121315A (en) | Oral compositions containing a zinc compound | |
US6348187B1 (en) | Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems | |
US5284648A (en) | Alcohol-free, oral rinse and pre-rinse emulsions method of prepration and method of use | |
US4150151A (en) | Mouthwash | |
US5891422A (en) | Antimicrobial composition containing a C3 -C6 alcohol | |
US3947570A (en) | Oral product | |
US4476107A (en) | Mouthwash composition | |
US6235267B1 (en) | Taste masking of phenolics using citrus flavors | |
US4465661A (en) | Oral product having improved taste | |
US5100650A (en) | Anti-bacterial oral composition containing bis-biguanido hexanes | |
GB2154139A (en) | Local oral germicide containing hydrogen peroxide | |
JPH10503196A (ja) | 殺菌性歯磨き | |
RU2552936C2 (ru) | Продукт для ухода за полостью рта и способы его применения и получения | |
CA2632337A1 (fr) | Aromatisation d'huiles essentielles au moyen d'un hydrocolloide | |
EP0854702B1 (fr) | Compositions antimicrobiennes contenant un alcool c 3-c 6 | |
WO1996016633A1 (fr) | Bain de bouche a teneur reduite en alcool | |
WO2011055707A1 (fr) | Composition de dentifrice | |
WO1997030685A1 (fr) | Bain de bouche a teneur alcoolique reduite | |
WO1996015770A1 (fr) | Compositions antimicrobiennes orales | |
JPH11322554A (ja) | 口腔用組成物 | |
JP3582571B2 (ja) | 口腔液体製剤 | |
CN111032004A (zh) | 口腔护理组合物 | |
JP2001322921A (ja) | 液体口腔用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP MX NZ SG |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |